Mona-Lisa Engman
Karolinska Institutet
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mona-Lisa Engman.
Pediatric Infectious Disease Journal | 2012
Mona-Lisa Engman; Katarina Lindström; Marie Sallamba; Carl Hertz; Berit Sundberg; Magnus E. A. Hansson; Lars Lindquist; Claes Örvell; Karl-Johan Lidefelt; Mikael Sundin
Background: Neurologic sequelae, including cognitive deficits, after childhood tick-borne encephalitis (TBE) and neuroborreliosis (NB) are not well-characterized. These infections are among the most common affecting the central nervous system in children and can be difficult to diagnose due to vague symptomatology. The aim of this study was to investigate long-term (>1 year) consequences of pediatric TBE and NB as well as the value of markers for brain damage and genetic susceptibility. Methods: From a previous prospective study, children diagnosed with TBE (n = 8) and NB (n = 12) as well as pediatric controls (n = 15) were followed up by clinical examination, semistructured interview and screening for cognitive dysfunction by the Five-to-Fifteen Questionnaire. The follow-up also included detection of serum autoantibodies against the neural proteins; glial fibrillary acidic protein and myelin basic protein, as well as genotyping of a 32 basepair deletion in the chemokine receptor type 5 gene. Results: Children diagnosed with TBE displayed significantly more long-term subjective complaints (ie, fatigue, headache and irritability) compared with the NB and control groups. Significantly higher frequency of disabilities was also detected by the Five-to-Fifteen Questionnaire in the TBE group. Both TBE and NB cause consequences (eg, prolonged convalescence, worries and financial loss) for the families. Markers for genetic susceptibility and brain damage had no prognostic values in this cohort. Conclusions: Pediatric TBE results in long-lasting residual symptoms and neurologic deficits affecting daily life. Vigilance for TBE-related morbidity among pediatricians and long-term clinical follow-up with assessment of cognitive dysfunctions and appropriate interventions seems reasonable for these children.
Acta Paediatrica | 2012
Eva Karltorp; Sten Hellström; Ilona Lewensohn-Fuchs; Eva Carlsson-Hansén; Per-Inge Carlsson; Mona-Lisa Engman
Aim: The aim of this study was to investigate the role of congenital cytomegalovirus (CMV) infection as a cause of various types of sensorineural hearing loss (SNHL) in a group of nonsyndromic children with otherwise unknown aetiology of hearing loss. Furthermore, the occurrence of combined congenital CMV infection and connexin 26 (Cx26) mutations was investigated.
Acta Paediatrica | 2014
Eva Karltorp; Ulrika Löfkvist; Ilona Lewensohn-Fuchs; Katarina Lindström; Mimmi Eriksson Westblad; Kristina Teär Fahnehjelm; Luca Verrecchia; Mona-Lisa Engman
Although cytomegalovirus (CMV) is the most common congenital infection, existing research has not provided us with a full picture of how this can affect children in the future. The aim of this case–control study was to evaluate disabilities in a well‐defined group of children with congenital cytomegalovirus (CMV) infection, who had been fitted with cochlear implants because of severe hearing impairment.
Scandinavian Journal of Immunology | 2013
Anna Karin Lidehäll; Mona-Lisa Engman; Fredrik Sund; Gunilla Malm; Ilona Lewensohn-Fuchs; Uwe Ewald; Thomas H. Tötterman; Eva Karltorp; Olle Korsgren; Britt-Marie Eriksson
Congenital cytomegalovirus (CMV) infection is the most common congenital infection causing childhood morbidity. The pathogenetic mechanisms behind long‐term sequelae are unclear, but long‐standing viremia as a consequence of the inability to convert the virus to a latent state has been suggested to be involved. Whereas primary CMV infection in adults is typically rapidly controlled by the immune system, children have been shown to excrete virus for years. Here, we compare T cell responses in children with congenital CMV infection, children with postnatal CMV infection and adults with symptomatic primary CMV infection. The study groups included 24 children with congenital CMV infection, 19 children with postnatal CMV infection and eight adults with primary CMV infection. Among the infants with congenital CMV infection, 13 were symptomatic. T cell responses were determined by analysis of interferon gamma production after stimulation with CMV antigen. Our results show that whereas adults display high CMV‐specific CD4 T cell responses in the initial phase of the infection, children younger than 2 years have low or undetectable responses that appear to increase with time. There were no differences between groups with regard to CD8 T cell function. In conclusion, inadequate CD 4 T cell function seems to be involved in the failure to get immune control of the CMV infection in children younger than 2 years of age with congenital as well as postnatal CMV infection.
Pediatric Infectious Disease Journal | 2011
Magnus E. A. Hansson; Claes Örvell; Mona-Lisa Engman; Katarina Wide; Lars Lindquist; Karl-Johan Lidefelt; Mikael Sundin
Retrospective evaluation of medical history and 3635 anti-TBE (tick-borne encephalitis) serologies during the years 2003–2008 indicates that childhood TBE is characterized by vague symptoms. Clinical findings suggest a nonspecific inflammatory disease with restricted encephalitic profile compared with adult TBE. Childhood TBE might elude diagnosis, which is unsatisfactory because of potential long-term consequences.
Acta Paediatrica | 2015
Mona-Lisa Engman; Mikael Sundin; Carmela Miniscalco; Joakim Westerlund; Ilona Lewensohn-Fuchs; Christopher Gillberg; Elisabeth Fernell
The aim of the study was to evaluate the prevalence of congenital cytomegalovirus infection (CMV) in a representative sample of children with autism spectrum disorder.
Acta Ophthalmologica Scandinavica | 2000
Kristina Teär Fahnehjelm; Gunilla Malm; Jan Ygge; Mona-Lisa Engman; Eva Maly; Birgitta Evengård
Acta Ophthalmologica Scandinavica | 2001
Kristina Teär Fahnehjelm; Jan Ygge; Mona-Lisa Engman; Mikael Mosskin; Pirkko Santavuori; Gunilla Malm
Archive | 2008
Anna Karin Lidehäll; Mona-Lisa Engman; Fredrik Sund; Gunilla Malm; Ilona Lewensohn-Fuchs; Uwe Ewald; Thomas H. Tötterman; Eva Karltorp; Olle Korsgren; Britt-Marie Eriksson
American Journal of Ophthalmology | 2001
Kristina Teär Fahnehjelm; Gunilla Malm; Jan Ygge; Mona-Lisa Engman; Eva Maly; Birgitta Evengård